INCONTRI CON L'ESPERTO – BPCO:ICS, LAMA, LABA – Comitato Regionale Friuli Venezia Giulia
Bpco, analisi post-hoc KRONOS: switch terapia da ICS/LABA a terapi
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
Algorithm for withdrawal of ICS in symptomatic patients with COPD. a... | Download Scientific Diagram
Chronic obstructive pulmonary disorder (COPD) inhaler criteria - Province of British Columbia
Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine
A new alphabet for COPD care | European Respiratory Society
American College of Chest Physicians - In a real-world setting, LAMA-LABA- ICS is as effective as LAMA-LABA to prevent COPD exacerbations, but incidence of pneumonia increased with triple therapy initiation: https://hubs.ly/H0pPLQ20 | Facebook
Evidence Summary - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma - NCBI Bookshelf
LABA/LAMA vs ICS/LABA for exacerbations - Management of Stable COPD - GOLD COPD 2017 Resource Center: Activity Five
effect of laBa/laMa versus laMa or laBa/ICs on safety outcomes | Download Table
Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study - ScienceDirect
Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar
Asthma & COPD Medications Chart - National Asthma Council Australia
Nuovi dati su ICS/LABA/LAMA vs LABA/LAMA per la BPCO • NCF
Ellipta Inhalers We have 5 total inhalers that are ... | GrepMed
LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: A systematic review and meta-analysis
Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box | European Respiratory Society
ICS/LABA/LAMA si dimostra superiore a LABA/LAMA per la BPCO • NCF
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine
Dr Robert Young_AsthmaFoundation.v5.2017
Figure 1 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
Pharmaceuticals | Free Full-Text | Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA
